Vera Therapeutics has come a long way towards the development of Atacicept for the treatment of patients with IgAN. Read more ...

Researchers have developed a noninvasive method called bioluminescent optogenetics (BL-OG), which uses light to activate neurons in the brain without the need for implanted devices.

Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

Psoriasis is a multifactorial immune-mediated inflammatory disease. Its pathogenesis involves abnormal accumulation of neutrophils and T-cell related abnormalities. Pyroptosis is a type of regulated ...

B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

For many years, scientists have known that genetic variants, or differences in DNA code across people, play some role in ...

University of Rochester researchers have demonstrated a noninvasive method using BL-OG, or bioluminescent optogenetics, that ...

The introduction of clustered enhancing mutations led to complement activation by anti-capsule antibodies for both K.

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today ...

Casitas B-lineage lymphoma b (Cbl/b) is an E3 ubiquitin ligase that has been shown to be a key regulator of the activation of T and natural killer (NK) cells in the absence of CD28 costimulation GRC ...